Total Payments
$95,374
2023 Payments
$17.02
Companies
9
Transactions
134
Payment Breakdown by Category
Other$75,395 (79.1%)
Travel$15,268 (16.0%)
Education$3,688 (3.9%)
Food & Beverage$1,024 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $75,395 | 44 | 79.1% |
| Travel and Lodging | $15,268 | 56 | 16.0% |
| Education | $3,688 | 7 | 3.9% |
| Food and Beverage | $1,024 | 27 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals America, Inc. | $44,202 | 60 | $0 (2017) |
| Takeda Pharmaceuticals U.S.A., Inc. | $41,960 | 51 | $0 (2022) |
| Alkermes, Inc. | $6,477 | 5 | $0 (2019) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $2,046 | 6 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $324.96 | 3 | $0 (2019) |
| Valeant Pharmaceuticals North America LLC | $132.17 | 2 | $0 (2017) |
| Lundbeck LLC | $120.91 | 5 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $84.75 | 1 | $0 (2017) |
| Sage Therapeutics, Inc. | $27.60 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $17.02 | 1 | Lundbeck LLC ($17.02) |
| 2022 | $75.77 | 4 | Lundbeck LLC ($38.58) |
| 2021 | $2,042 | 6 | Otsuka Pharmaceutical Development & Commercialization, Inc. ($2,007) |
| 2020 | $27.60 | 1 | Sage Therapeutics, Inc. ($27.60) |
| 2019 | $16,557 | 18 | Takeda Pharmaceuticals U.S.A., Inc. ($11,341) |
| 2018 | $25,527 | 33 | Takeda Pharmaceuticals U.S.A., Inc. ($24,029) |
| 2017 | $51,127 | 71 | Takeda Pharmaceuticals America, Inc. ($44,202) |
All Payment Transactions
134 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/30/2023 | Lundbeck LLC | — | Food and Beverage | Cash or cash equivalent | $17.02 | General |
| 10/12/2022 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.49 | General |
| Category: PSYCHIATRY | ||||||
| 05/19/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: NEUROSCIENCE | ||||||
| 03/22/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: NEUROSCIENCE | ||||||
| 02/08/2022 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.09 | General |
| Category: PSYCHIATRY | ||||||
| 10/20/2021 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,620.00 | General |
| 10/20/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: NEUROSCIENCE | ||||||
| 07/30/2021 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $16.80 | General |
| Category: PSYCHIATRY | ||||||
| 06/09/2021 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | In-kind items and services | $20.28 | General |
| 04/14/2021 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $351.00 | General |
| 04/09/2021 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | In-kind items and services | $15.45 | General |
| 08/24/2020 | Sage Therapeutics, Inc. | — | Education | In-kind items and services | $27.60 | General |
| 09/06/2019 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | In-kind items and services | $18.01 | General |
| 07/24/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Vyvanse (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Central Nervous System (CNS) | ||||||
| 03/21/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $638.00 | General |
| Category: Central Nervous System (CNS) | ||||||
| 03/21/2019 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $77.89 | General |
| Category: PSYCHIATRY | ||||||
| 03/18/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $638.00 | General |
| Category: Central Nervous System (CNS) | ||||||
| 03/13/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $638.00 | General |
| Category: Central Nervous System (CNS) | ||||||
| 03/12/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $638.00 | General |
| Category: Central Nervous System (CNS) | ||||||
| 03/08/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $638.00 | General |
| Category: Central Nervous System (CNS) | ||||||
| 03/05/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,678.00 | General |
| Category: Central Nervous System (CNS) | ||||||
| 03/05/2019 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | In-kind items and services | $20.94 | General |
| 03/04/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $638.00 | General |
| Category: Central Nervous System (CNS) | ||||||
| 02/27/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,913.00 | General |
| Category: Central Nervous System (CNS) | ||||||
| 02/19/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Travel and Lodging | In-kind items and services | $901.20 | General |
| Category: Central Nervous System (CNS) | ||||||
About Harry Croft
Harry Croft is a Specialist healthcare provider based in San Antonio, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/24/2007. The National Provider Identifier (NPI) number assigned to this provider is 1790830263.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Harry Croft has received a total of $95,374 in payments from pharmaceutical and medical device companies, with $17.02 received in 2023. These payments were reported across 134 transactions from 9 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($75,395).
Ad
Practice Information
- Specialty Specialist
- Location San Antonio, TX
- Active Since 01/24/2007
- Last Updated 02/17/2017
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1790830263
Products in Payments
- Trintellix (Drug) $82,143
- ABILIFY MAINTENA (Drug) $341.76
- Entyvio (Biological) $196.20
- TRINTELLIX (Drug) $194.46
- ADDYI (Drug) $132.17
- LATUDA (Drug) $84.75
- REXULTI (Drug) $38.58
- Vyvanse (Drug) $16.24
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in San Antonio
Carl Dukes, Md, MD
Specialist — Payments: $411,947
Specialist $411,947
Dr. Vivian Bucay, M.d, M.D
Specialist — Payments: $379,124
Specialist $379,124
Marra Francis, M.d, M.D
Specialist — Payments: $376,663
Specialist $376,663
Dr. James Andry, Md, MD
Specialist — Payments: $204,754
Specialist $204,754
John Holcomb, M.d, M.D
Specialist — Payments: $181,185
Specialist $181,185
Dr. Russell Woodard, M.d, M.D
Specialist — Payments: $62,593
Specialist $62,593